Report offers ways to address cybersecurity challenges posed by legacy medical devices

The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
In a statement submitted to the Senate Health, Education, Labor and Pensions Committee for a hearing today on health care cybersecurity and patient privacy,…
Headline
Cyberattacks on hospitals are urgent threats to patient safety, care delivery and public trust. In this conversation, Ajay Gupta, board chair of Trinity Health…
Headline
The Food and Drug Administration yesterday released a safety notice announcing a software patch is available to address cybersecurity vulnerabilities in…
Headline
The Cybersecurity and Infrastructure Security Agency, FBI, Department of Defense Cyber Crime Center and the National Security Agency June 30 released a fact…
Headline
The Centers for Medicare & Medicaid Services today announced it has identified a fraud scheme targeting Medicare providers and suppliers. CMS said scammers…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used…